These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33797369)

  • 1. Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Top Med Chem; 2021; 21(21):1871-1899. PubMed ID: 33797369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.
    Rocha DA; Silva EB; Fortes IS; Lopes MS; Ferreira RS; Andrade SF
    Eur J Med Chem; 2018 Sep; 157():1426-1459. PubMed ID: 30282318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cysteine proteases in trypanosomatid disease drug discovery.
    Ferreira LG; Andricopulo AD
    Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
    Mott BT; Ferreira RS; Simeonov A; Jadhav A; Ang KK; Leister W; Shen M; Silveira JT; Doyle PS; Arkin MR; McKerrow JH; Inglese J; Austin CP; Thomas CJ; Shoichet BK; Maloney DJ
    J Med Chem; 2010 Jan; 53(1):52-60. PubMed ID: 19908842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria.
    Di Chio C; Starvaggi J; Totaro N; Previti S; Natale B; Cosconati S; Bogacz M; Schirmeister T; Legac J; Rosenthal PJ; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases.
    Eurtivong C; Zimmer C; Schirmeister T; Butkinaree C; Saruengkhanphasit R; Niwetmarin W; Ruchirawat S; Bhambra AS
    Mol Divers; 2024 Apr; 28(2):531-551. PubMed ID: 36617352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
    Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
    Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Inhibitors of Cruzain Cysteine Protease of
    Prates JLB; Lopes JR; Chin CM; Ferreira EI; Dos Santos JL; Scarim CB
    Curr Med Chem; 2024; 31(16):2285-2308. PubMed ID: 37888814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzimidazole inhibitors of the major cysteine protease of
    Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
    Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
    [No Abstract]   [Full Text] [Related]  

  • 12. Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.
    Silva LR; Guimarães AS; do Nascimento J; do Santos Nascimento IJ; da Silva EB; McKerrow JH; Cardoso SH; da Silva-Júnior EF
    Bioorg Med Chem; 2021 Jul; 41():116213. PubMed ID: 33992862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Ettari R; Tamborini L; Angelo IC; Micale N; Pinto A; De Micheli C; Conti P
    J Med Chem; 2013 Jul; 56(14):5637-58. PubMed ID: 23611656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy.
    Caffrey CR; Scory S; Steverding D
    Curr Drug Targets; 2000 Sep; 1(2):155-62. PubMed ID: 11465068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl ureas represent a new class of anti-trypanosomal agents.
    Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
    Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Optimization of Quinazolines as Cruzain and
    Barbosa da Silva E; Rocha DA; Fortes IS; Yang W; Monti L; Siqueira-Neto JL; Caffrey CR; McKerrow J; Andrade SF; Ferreira RS
    J Med Chem; 2021 Sep; 64(17):13054-13071. PubMed ID: 34461718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid-Compounds Against Trypanosomiases.
    Nunes JA; Ferreira da Silva-Júnior E
    Curr Drug Targets; 2022; 23(14):1319-1329. PubMed ID: 35579157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification.
    Braga SF; Martins LC; da Silva EB; Sales Júnior PA; Murta SM; Romanha AJ; Soh WT; Brandstetter H; Ferreira RS; de Oliveira RB
    Bioorg Med Chem; 2017 Mar; 25(6):1889-1900. PubMed ID: 28215783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
    Pereira GAN; da Silva EB; Braga SFP; Leite PG; Martins LC; Vieira RP; Soh WT; Villela FS; Costa FMR; Ray D; de Andrade SF; Brandstetter H; Oliveira RB; Caffrey CR; Machado FS; Ferreira RS
    Eur J Med Chem; 2019 Oct; 179():765-778. PubMed ID: 31284086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.
    Nicoll-Griffith DA
    Expert Opin Drug Discov; 2012 Apr; 7(4):353-66. PubMed ID: 22458506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.